Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Pablo Legorreta
Pablo Legorreta is recorded as Chairman and Board Member at Prokidney Corp. (PROK). Prokidney Corp. reported in an 8-K filed July 12, 2022 that Pablo Legorreta was appointed Chairperson of the ProKidney Corp. board of directors. Prokidney Corp. reported in an 8-K filed July 12, 2022 that Pablo Legorreta was appointed Class III director. Pablo Legorreta has spoken on 1 earnings call across 1 company, most recently for Prokidney Corp. on November 14, 2023.
“SCS shareholders approved by ordinary resolution the election of William F. Doyle, Alan M. Lotvin, M.D. and Brian J.G. Pereira, M.D. to serve as Class I directors, John M. Maraganore, Ph.D. and José Ignacio Jiménez Santos to serve as Class II directors and Tim Bertram, Ph.D., Pablo Legorreta and Uma Sinha, Ph.D. to serve as Class III directors, with Mr. Legorreta to serve as the Chairperson of the ProKidney Corp. board of directors, who, upon the Closing, will be the directors of ProKidney Corp.”
Prokidney Corp. Form 8-K, filed July 12, 2022
· Read the filing
“SCS shareholders approved by ordinary resolution the election of William F. Doyle, Alan M. Lotvin, M.D. and Brian J.G. Pereira, M.D. to serve as Class I directors, John M. Maraganore, Ph.D. and José Ignacio Jiménez Santos to serve as Class II directors and Tim Bertram, Ph.D., Pablo Legorreta and Uma Sinha, Ph.D. to serve as Class III directors, with Mr. Legorreta to serve as the Chairperson of the ProKidney Corp. board of directors, who, upon the Closing, will be the directors of ProKidney Corp.”
Prokidney Corp. Form 8-K, filed July 12, 2022
· Read the filing
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
